Hospital Galdakao-Usansolo
35
2
3
27
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.9%
1 terminated/withdrawn out of 35 trials
96.4%
+9.9% vs industry average
6%
2 trials in Phase 3/4
7%
2 of 27 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (35)
RICA (ERAS) Pathway Adherence and Early Discharge Feasibility After Urgent Uncomplicated Appendectomy (APENERAS)
Role: lead
Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients
Role: collaborator
Poor Outcomes Among Patients Aged 65 and Older Presenting to the Emergency Department(EDEN-RICAPPS Study)
Role: lead
Autoantibodies in Treatment with Immune Checkpoint Inhibitors (AUTENTIC)
Role: collaborator
COVID-19, Patients' Evolution and the Influence of the Pandemic on Health Care and Outcomes in Chronic Diseases
Role: lead
Clinical Deterioration Early Warning System Score
Role: lead
Creation, Implementation and Validation of Intra- and Postoperative Risk Prediction Models
Role: lead
Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation
Role: lead
COVID19 Severity Prediction and Health Services Research Evaluation
Role: lead
Advanced Modeling of the Evolution of the Epidemiological Outbreak of SARS-CoV-2 Pandemic
Role: lead
Bispectral Index Monitoring for Sedation in Elective Colonoscopies of Adult Patients: a Randomized Controlled Trial
Role: lead
Identification of Multimorbid Patients With a Higher Probability of Readmission and Mortality
Role: lead
Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition
Role: lead
Efficacy of the Infusion of Donor Plasma in COVID-19 Infection
Role: lead
Peri-Implant and Peri-Prosthetic Fractures: Epidemiology, Morbidity, Mortality, Treatment and Outcome Analysis
Role: collaborator
COPD Readmissions Prediction- ReCOPD Project
Role: lead
Predictive Models of Readmission in Heart Failure
Role: lead
Leukocyte Morphological Parameters as Prognostic Markers in CAP
Role: lead
Morphological Parameters of Blood Cell's Activation in Characterization and Prognosis in a COPD Patients Cohort
Role: lead
Safety and Effectiveness of Drug up Titration by Nurses Specialized in Heart Failure (HF) Patients
Role: lead